BE879471A - Solution stable d'erythromycine - Google Patents

Solution stable d'erythromycine

Info

Publication number
BE879471A
BE879471A BE1/9572A BE1009572A BE879471A BE 879471 A BE879471 A BE 879471A BE 1/9572 A BE1/9572 A BE 1/9572A BE 1009572 A BE1009572 A BE 1009572A BE 879471 A BE879471 A BE 879471A
Authority
BE
Belgium
Prior art keywords
erythromycin
stable solution
stable
solution
Prior art date
Application number
BE1/9572A
Other languages
English (en)
Inventor
H Takruri
J E Chavers
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BE879471A publication Critical patent/BE879471A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BE1/9572A 1978-10-20 1979-10-18 Solution stable d'erythromycine BE879471A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95315978A 1978-10-20 1978-10-20

Publications (1)

Publication Number Publication Date
BE879471A true BE879471A (fr) 1980-04-18

Family

ID=25493654

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/9572A BE879471A (fr) 1978-10-20 1979-10-18 Solution stable d'erythromycine

Country Status (13)

Country Link
EP (1) EP0010437B1 (fr)
JP (1) JPS5557519A (fr)
AU (1) AU529422B2 (fr)
BE (1) BE879471A (fr)
CA (1) CA1129772A (fr)
CH (1) CH642544A5 (fr)
DE (1) DE2967163D1 (fr)
FR (1) FR2439016A1 (fr)
GB (1) GB2031728B (fr)
IE (1) IE49086B1 (fr)
LU (1) LU81799A1 (fr)
NZ (1) NZ191847A (fr)
ZA (1) ZA795492B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59104326A (ja) * 1982-12-04 1984-06-16 Toyo Jozo Co Ltd マクロライド抗生物質の安定な経口用製剤および安定化法
ATE84667T1 (de) * 1986-01-31 1993-02-15 Whitby Research Inc Hautpenetration verbessernde zusammensetzungen.
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
FI883337A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Icke-vattenloesningar av doxorubicinhydroklorin.
FI883338A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Vattenloesningar av doxorubicinhydroklorid.
JPH0737389B2 (ja) * 1989-08-29 1995-04-26 久光製薬株式会社 プロスタグランジンｅ１含有の軟膏剤
DE19549794B4 (de) * 1994-10-26 2009-07-30 Novartis Ag Pharmazeutische Zusammensetzungen
GB2327611B (en) * 1994-10-26 1999-06-02 Novartis Ag Macrolide compositions
US5723447A (en) * 1996-07-02 1998-03-03 Rhone Merieux, Inc. Water miscible erythromycin solutions
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
WO2002078669A1 (fr) * 2001-03-30 2002-10-10 Takeda Chemical Industries, Ltd. Solutions medicinales

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000263A (en) * 1975-05-02 1976-12-28 Westwood Pharmaceuticals, Inc. Erythromycin solution
FR2378523A1 (fr) * 1977-01-26 1978-08-25 Grupper Charles Medicament pour le traitement de l'acne

Also Published As

Publication number Publication date
IE49086B1 (en) 1985-07-24
EP0010437B1 (fr) 1984-08-08
ZA795492B (en) 1981-05-27
EP0010437A3 (en) 1981-05-13
NZ191847A (en) 1982-05-31
AU529422B2 (en) 1983-06-09
CA1129772A (fr) 1982-08-17
GB2031728B (en) 1983-02-16
JPS5557519A (en) 1980-04-28
EP0010437A2 (fr) 1980-04-30
FR2439016B1 (fr) 1983-05-27
JPH0157097B2 (fr) 1989-12-04
LU81799A1 (fr) 1980-01-25
IE791995L (en) 1980-04-20
GB2031728A (en) 1980-04-30
FR2439016A1 (fr) 1980-05-16
AU5179079A (en) 1980-04-24
CH642544A5 (fr) 1984-04-30
DE2967163D1 (en) 1984-09-13

Similar Documents

Publication Publication Date Title
BE869612A (fr) Preparation d'oligoimides
BR8002776A (pt) Estrutura de bracadeira
BE875773A (nl) 2'deoxy-5-(halogeenvinyl)-uridines
DK198279A (da) Dialyseoploesning (2)
BE873813R (fr) Preparation d'oligoimides
ATE202T1 (de) 2-cycloalkyl-pyrimidin(5)
AT383473B (de) Kleinkinderhoeschen
BE878174A (fr) Wandbekleding of vloerbekleding
BE879471A (fr) Solution stable d'erythromycine
TR20622A (tr) 4-halometilpiridinlerin eterleri
LU81342A1 (fr) Preparations anti-caries
FI790004A (fi) 4"-deoxi-4"-acylamidoderivat av oleandomycin och erytromycinkarbonat
DK39079A (da) Stabilt praeparat
BE864321A (fr) Derives d'acide oxazolinoazetidinylbutyrique
FR2377438B1 (fr) Emulsions stables d'alkylhydridopolysiloxannes
BE866606A (fr) Nouveaux analogues de l'anthracycline
IT1133703B (it) Unita' portante
FI791011A (fi) 3-0-(beta-d-glukuronopyranosyl)-sojasapogenol b
DK529879A (da) Galeniske praeparater indehldende ergotalkaloider
BE843183A (fr) Solution d'iodophores
LU81071A1 (fr) Vitrai 12
FI790141A (fi) 2 6-dinitrobensenaminer
MC1285A1 (fr) Derives d'isoquinoleine
BE855126A (fr) Preparation d'ethylene-glycol
LU80742A1 (fr) Nouveaux derives de 11-alcanoyl-4"-deoxy-4"-isonitrilo-oleandomyeine

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: ELI LILLY AND CY

Effective date: 19991018